Notable Upgrades: Ambarella (AMBA), Starbucks (SBUX), Eli Lilly (LLY), Mobileye N.V. (MBLY), Herbalife (HLF)

Ambarella, Inc. (AMBA) was reiterated a ‘Buy’ by Stifel analysts on Thursday. The broker also raised its price target on the stock to $115 from $105.

Ambarella, Inc. shares are currently priced at 53.33x this year’s forecasted earnings compared to the industry’s 18.56x earnings multiple. Ticker has a PEG and forward P/E ratio of 1.64 and 28.59, respectively. Price/Sales for the same period is 12.82 while EPS is $1.95. Currently there are 7 analysts that rate AMBA a ‘Buy’, 5 rate it a ‘Hold’. No analyst rates it a ‘Sell’. AMBA has a median Wall Street price target of $105.00 with a high target of $123.00.

In the past 52 weeks, shares of Santa Clara, Calif.-based company have traded between a low of $27.40 and a high of $128.06 and are now at $104.21. Shares are up 224.91% year-over-year and 100.32% year-to-date.

Starbucks Corporation (SBUX) was reiterated as ‘Overweight’ with a $63 from $55 price target on Thursday by Piper Jaffray.

SBUX shares recently gained $0.46 to $54.17. In the past 52 weeks, shares of Seattle, Washington-based company have traded between a low of $35.39 and a high of $54.45. Shares are up 40.73% year-over-year and 31.82% year-to-date.

Eli Lilly and Company (LLY) was raised to ‘Buy‘ from ‘Neutral‘ at BofA/Merrill (BAC) on Thursday.

LLY is up $3.66 at $85.92 on heavy volume. Midway through trading Thursday, 6.07 million shares of Eli Lilly & Co. have exchanged hands as compared to its average daily volume of 5.60 million shares. The stock has ranged in a price between $84.10 – $86.84 after having opened the day at $84.16 as compared to the previous trading day’s close of $82.26.

Over the past year, shares of Indianapolis, Indiana-based pharmaceutical company have traded between a low of $60.14 and a high of $87.24. Shares are up 36.86% year-over-year and 20.92% year-to-date.

Investment analysts at Credit Agricole initiated coverage on shares of Mobileye N.V. (MBLY) in a note issued to investors on Thursday. The firm set a ‘Buy‘ rating and a $67 price target on the stock. The firm’s price target would suggest a potential upside of 21% from the stock’s current price of $55.27.

Mobileye N.V., currently valued at $11.97 billion, has a median Wall Street price target of $59.00 with a high target of $70.00. Approximately 4.24 million shares have already changed hands, compared to the stock’s average daily volume of 3.52 million.

In the past 52 weeks, shares of Jerusalem, Israel-based company have traded between a low of $31.11 and a high of $60.28 with the 50-day MA and 200-day MA located at $48.48 and $42.89 levels, respectively. Additionally, shares of MBLY have a Relative Strength Index (RSI) and MACD indicator of 69.71 and +2.58, respectively.

Mobileye N.V. currently prints a year-to-date return of around 30.77%.

Herbalife Ltd. (HLF) price target has been raised from $80.00 to $90.00 by Pivotal Research analysts, according to a research note published on Thursday. The new price target represents a potential upside of about 64% from the current share price.

HLF shares recently gained $0.95 to $54.93. The stock is down more than 15% year-over-year and has gained roughly 43% year-to-date. In the past 52 weeks, shares of George Town, the Cayman Islands-based company have traded between a low of $27.60 and a high of $69.69.

Herbalife Ltd. closed Wednesday at $53.98. The name has a current market cap of $5.08 billion.

Be the first to comment

Leave a Reply

Your email address will not be published.


*